Lexeo Therapeutics (LXEO) Prepaid Assets (2022 - 2026)
Lexeo Therapeutics (LXEO) posted Prepaid Assets of $7.8 million for Q1 2026, up 18.02% sequentially from $6.6 million in Q4 2025, and up 43.65% YoY from $5.4 million in Q1 2025.
Lexeo Therapeutics (LXEO) Prepaid Assets (2022 - 2026) Analysis & Trends
Lexeo Therapeutics has reported Prepaid Assets for 5 years, with the latest figure at $7.8 million in Q1 2026.
- Quarterly Prepaid Assets rose 43.65% year-over-year to $7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.8 million (up 43.65% YoY) and the FY2025 annual result came in at $6.6 million, up 43.93% from the prior year.
- Prepaid Assets improved to $7.8 million in Q1 2026 per LXEO's latest filing, from $6.6 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $7.8 million in Q1 2026 and troughed at $1.4 million in Q3 2023.
- A 5-year average of $4.2 million and a median of $3.8 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets grew 20.75% in 2023, then jumped 230.67% in 2025.
- Over 5 years, Prepaid Assets stood at $2.3 million in 2022, then advanced by 20.75% to $2.8 million in 2023, then soared by 62.77% to $4.6 million in 2024, then jumped by 43.93% to $6.6 million in 2025, then grew by 18.02% to $7.8 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $7.8 million, $6.6 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lexeo Therapeutics | 397.10 Mn | 397.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.21 Mn |
| Mar 31, 2026 | 7.82 Mn |
| Dec 31, 2025 | 6.63 Mn |
| Sep 30, 2025 | 5.03 Mn |
| Jun 30, 2025 | 7.17 Mn |
| Mar 31, 2025 | 5.44 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | 2.17 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 2.83 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Dec 31, 2022 | 2.34 Mn |